Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Retinol acetate can reduce the harmful effects of the drug benoxaprofen on white blood cells.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

A fungal enzyme was used to make compounds more soluble, aiding drug discovery and crop protection.

The MPA-ISO cocrystal improved solubility and dissolution rate, while the others did not.

Topical treatment with amphotericin B and DMSO effectively healed a horse's skin infection.

Genetically modifying a bacteria and changing its growth conditions significantly increased the production of a chemical called dipicolinic acid.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

MYB30 and EIN3 work against each other to control root hair growth and phosphorus uptake in plants when phosphate is low.

Geranyl acetate can protect skin cells from damage and inflammation caused by para-phenylenediamine.

Adding zinc to pyrithione zinc improves its effectiveness against scalp conditions like dandruff.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Topical 17 alpha-propylmesterolone increases hair cell growth in androgenetic alopecia.

Palmitoyl tetrapeptide-20 may help reduce hair greying and increase melanin production.

MsPG3 protein gathers at root hair tips, aiding growth.

S-Methylmethionine sulfonium can protect skin from UVB damage.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

Modified pep7, named EPM peptide, effectively promotes hair growth at low concentrations and works well with minoxidil.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

Photodynamic therapy with methylene blue and a laser effectively destroys hair follicles better than traditional laser hair removal.

New method makes important drug ingredients more easily without needing extra purification steps.